Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing early predictors of poor treatment response in schizophrenia patients treated with atypical antipsychotics. The study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atypical antipsychotics

Snippet

Sponsor: Calo Psychiatric Center | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED